Experimental Study of the Effects of Marrow Mesenchymal Stem Cells Transfected with Hypoxia-Inducible Factor-1α Gene by Yang, Jinfu et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2009, Article ID 128627, 10 pages
doi:10.1155/2009/128627
Research Article
ExperimentalStudy of the Effectsof Marrow MesenchymalStem
CellsTransfectedwith Hypoxia-Inducible Factor-1α Gene
Jinfu Yang,1 Tao Tang,1 FengLi,1 Wenwu Zhou,2 Jian Liu,2 ZhipingTan,1 Wei Zheng,3
Yifeng Yang,1 XinminZhou,1 andJianguoHu1
1Department of Cardiothoracic Surgery, Second Xiangya Hospital, Central South University, Hunan, Changsha 410011, China
2Department of Cardiothoracic Surgery, Hunan Children’s Hospital, Hunan, Changsha 410007, China
3Department of General Surgery, Human Provincial People’s Hospital, Hunan, Changsha 410005, China
Correspondence should be addressed to Tao Tang, tangtao2001@163.com
Received 11 February 2009; Revised 9 April 2009; Accepted 15 April 2009
Recommended by Omar Benzakour
Objective. To construct the eukaryotic expression vector hypoxia-inducible factor 1α-pcDNA3.1 and to investigate its transfective
eﬃciency into mesenchymal stem cells (MSCs) in vitro and the expression of HIF-1α gene in MSCs. Methods. mRNA of Wistar
Rats’ myocardial cells was extracted, and cDNA was synthesized with Reverse Transcription Kit, HIF-1α was ampliﬁed by
polymerasechainreaction(PCR),andconstructedintopcDNA3.1.TransfectedHIF-1α-pcDNA3.1 intoMSCsbyliposomemediated
method. The expression of HIF-1α in the cells was detected by Western Blot Analysis and ELISA. Results. Eukaryotic expression
vector HIF-1α-pcDNA3.1 was constructed successfully. Analyzed by ﬂow cytometer, The MSCs’ surfaces mark were CD44+,
SH3(CD73)+, CD34−,C D 4 5 − and the CD44+ cells and SH3(CD73)+ cells were 94.7% and 97.3%, respectively, showing the high
purity of the cultured MSCs. After inducing, the cultured MSCs can diﬀerentiate into osteoblasts and adipocytes successfully. In
HIF-1α gene transfected MSCs, the expression of HIF-1α mRNA and HIF-1α protein were both increased obviously. Conclusion.
HIF-1α was cloned successfully. HIF-1α-pcDNA3.1 can be transfected into MSCs by liposome-mediated method eﬀectively and
which resulting stable expression of HIF-1α in transfected MSCs.
Copyright © 2009 Jinfu Yang et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Background
The pathological mechanism of ischemic heart disease
(IHD) is thought that the irreversible loss of the functional
cardiomyocytes, which are eventually replaced by ﬁbrous
noncontractile cells, followed by ventricular remodeling and
thancongestiveheartfailure.Dueto thehigh occurrenceand
mortality, the IHD has become one of the most serious dis-
eases which jeopardize human health [1]. One of the present
researchhotpointforIHDistherapeuticangiogenesis,which
can be achieved by three ways, that are the growth factor
protein therapy, cell transplant and gene therapy. There were
some clinical trials using naked plasmid vascular endothelial
growth factor-A165 to treat patients with stable angina
pectoris[2]orwithseverechronicischemicheartdisease[3].
Althoughthesetwostudiessuggestedthatthegenetreatment
wassafe,theclinicalsigniﬁcanceofgenetherapyhasnotbeen
demonstrated convincingly which emphasizes the need for
new treatment modalities, that is, the exogenous therapeutic
gene transfected MSC.
Hypoxia-inducible factor-1α (HIF-1α)i sat r a n s f e c t e d -
active nucleoprotein induced by cells under hypoxia condi-
tions, which can enhance the production of corresponding
proteins and launches the process of angiogenesis by binding
to the hypoxia response elements (HRE) of the vascular
endothelial growth factor (VEGF), transforming growth
factor-β and their receptors, and in turn improves the
cardiomyocytes’ adaptability to ischemic condition. Gene
therapy using HIF-1α as the target gene has two major
advantages;oneishighereﬀectthanotherdownstreamgenes
such as VEGF, ANG-2 and the other is the feasibility of
control because of lower risk of resulting angioma.
Marrow mesenchymal stem cells (MSCs), early cells of
themesoderm,arepresentinadultmarrowtissue.Thesecells
can “self-renew” and have the plasticity to diﬀerentiate into
multiple tissues. Some advantages of MSCs are that they can2 Journal of Biomedicine and Biotechnology
be isolated easily from a variety of sources, have genetic sta-
bility, and do not carry immunological or ethical concerns.
Hence, they were considered very suitable candidate donor
cells for stem cell therapy. And therefore, transplantation
of MSCs transfected with HIF1α into infarcted heart area
may have a synergic eﬀect in myocytes regeneration and
angiogenesis which contribute to better outcome than either
gene therapy or cell therapy alone.
2.MaterialsandMethods
The Wistar rats (Laboratory Animal Center, the 2nd Xiangya
Hospital, Central South University) received humane care
in compliance with the “Guide for the Care and Use of
Laboratory Animals” prepared by the Institute of Laboratory
AnimalResources,NationalResearchCouncil,andpublished
by the “Guide to the Care and Use of Experimental Animals”
by the Chinese Council on Animal Care.
2.1. RNA Extract and Analysis. RNA was extracted accord-
ing to protocols listed in the commercially available kit.
The quality of resulted RNA samples was assayed by the
absorption value in 260bp and 280bp (value of OD260/280
between 1.8 to 2.0 indicating high purity) and the yield
of RNA was calculated according to 1 OD260 equals to
40μg RNA. Finally, the integrity of the extracted RNA and
contamination of DNA were determined by formaldehyde
denaturation agarose electrophoresis.
2.2. Synthesis of cDNA. cDNA was synthesized by a Reverse
Transcription System Kit (Promega) following the protocols
listed in instructions.
2.3. HIF-1α PCR Ampliﬁcation (GenBank’s Reception Num-
ber:EF100708). TheprimersforPCRweredesignedbyusing
NCBI’s site based on Wistar rats’ HIF-1α mRNA sequences
from GenBank. The Wistar rats’ speciﬁc primers for HIF-
1α mRNA were designed by using Primer 3 software. The
forward primer was 5 -ATG GAG GGC GCC GGC GG-
3 , with a Hind III restriction enzyme cutting site being
inducted. The reverse primer was 5 -GTT AAC TTG ATC
CAAAGCTCT-3 ,withaBamHIrestrictionenzymecutting
site being inducted. The length of ampliﬁed segment was
2480bp.
PCR products were detected by electrophoresis in 1%
agarose gel. Cut oﬀ the gel carrying target segment under
viltalight lamp. Retrieved and puriﬁed the target gene
segment by using gel extraction Kit, then cloned TA as
routinely.
2.4. Cloning of HIF-1α to T Vector. The RT-PCR products of
HIF-1α’s coding region were cloned to pGEM-T vector. HIF-
1α was subcloned to pcDNA3.1 vector.
2.5.Isolation,Culture,andIdentiﬁcationofMCSs. Mesenchy-
mal stem cells (MSCs) from 6 weeks old Wistar rats were
obtained by density gradient centrifugation and puriﬁed on
the basis of their ability to adhere to plastic. In short, the
cells were isolated from the bone marrow of limb bones and
separated by gradient centrifugation with 1.073g/mL Percoll
solution (Promega, USA). The cells were cultured in low
carbohydrate Dulbecco’s modiﬁed Eagle’s medium (Gibco
BRL, USA) at 37
◦C in a humidiﬁed atmosphere containing
5% carbon dioxide (Forma, USA).
Cytoactive detection of MCSs: 20μL MSCs heavy sus-
pensions were stained with typan blue, which turned the
deadcellsbluewhilethelivingcellsremainedunstained,then
counted the total cellular scores in the four big squares of the
cell counting chamber. Counted 200 MSCs, and calculated
the ratio of living cells by using the formula: living cells
percentage = viable count/total cell count × 100%.
The growth curve in day 1 to day 11 of MSCs was
drawn. After MSCs were cultured in vitro for 4 weeks, Flow
cytoMeter (FCM) (FACSort, B-D Co., USA) was used to
analyze the superﬁcial markers such as CD34, CD44, CD45
and SH3 of MSCs. Osteoblast diﬀerentiation from MSCs
was induced by dexamethasone, β-glycerol phosphate and
ascorbic acid, and shown by alizarin S on day 14. Adipocyte
diﬀerentiationfromMSCswasinducedbyinsulinandshown
b yS u d a nI Vo nd a y2 1 .
2.6. HIF-1α Gene Transfect into MSCs
2.6.1. Extraction and Identiﬁcation of Plasmid. The bacterial
ﬂuid was shifted into 500mL centrifuge tubes and centrifu-
gated at 4◦C with the speed of 12,000rpm for 10 minutes,
and the supernatant was removed. Plasmid was extracted by
using QIAGEN Plasmid Maxi Kit following the protocols
listed in instructions. The extracted products were cut by
Enzyme Hind III and Enzyme BamH I, and then detected
by electrophoresis in 1% agarose gel. The extracted products
were cut by enzymes at 37
◦C according to the following bi-
enzyme cutting system: HIF-1α-pcDNA3.1/eGFP (National
Key Genetic Laboratory, China) plasmid 1μg, Hind III 2U,
BamH I 2U, Kbuﬀer 2μL, water added up to 20μL, enzyme
cutting with water bath at 37
◦Cf o r4h o u r s ,t h e nd e t e c t e db y
electrophoresis in 1% agarose gel.
2.6.2. HIF-1α-pcDNA3.1/eGFP Transfect into MSCs Mediated
by Lipofectamine2000. After several methods about tranfec-
tion were tested, the following procedure of tranfection was
ﬁnally used. Brieﬂy: 24 hours before the transfection, the
4th generation MSCs, whose growth conﬂuence rate reached
around 80∼90%, were digested by 0.05% Trypsin/0.02%
EDTA and than vaccinated to 12-pore plates with apinoid
sterilized round cover glasses (about 1 × 105 MSCs/pore,
each pore containing 1mL L-DMEM culture solution with
15% fetal bovine serum) and cultured in an incubator with
carbon dioxide at 37
◦C in a saturated humidity atmosphere
containing 5% carbon dioxide. The MSCs were transfected
with HIF-1α-pcDNA3.1/eGFP plasmid by using Lipofec-
tamine2000 Kit following the protocols listed in instructions
strictly. The ﬂuid was changed totally after culturing for
24 hours; about 10% of the dead cells were removed with
the abandoned ﬂuid. The rest was cultured for passage and
ampliﬁcation until reaching 80∼90% conﬂuence.
2.6.3. Detection of the Expression of HIF-1α Gene in Target
Cells. The marker gene, eGFP, can be expressed at the sameJournal of Biomedicine and Biotechnology 3
chronergy of the target gene. The expression of marker gene
observed by ﬂuorescence can reﬂect the expression of target
gene indirectly. The transfected cells were taken out of the
incubator at diﬀerent time. The expression of ﬂuorescence
was observed by using invert microscope with the excitation
wave length of 490nm.
Hoechst 33342 is a DNA binding ﬂuorescence dyes used
to dye living cells owing to its ability of penetrating intact
cell membranes and can give out blue ﬂuorescence with the
action of excitation light at 350nm. We used Hoechst 33342
marked nucleus as total cell number, and eGFP marked
nucleus as transfected cell number to assay the transient
transfection eﬃciency.
To detect the expression of HIF-1α at transcriptional
level, RT-PCR was used. The forward primer was 5 -ATG-
GAGGGCGCCGGCGG-3 , the reverse primer was 5 -GTT-
AACTTGATCCAAAGCTCT-3 . The length of the product
was2480bp.InnerreferencewasGAPDH,itsforwardprimer
was 5 -GGGGTGAGGCCGGTGCTGAGTA-3 , the reverse
primer was 5 -CATTGGGGGTAGGAACACGGAAGG-3 .
The length of the product was 459bp. PCR products were
detected by electrophoresis in 2% agarose gel. Bio-Rad
image analysis software was used as semiquantitative analysis
of the absorbance capacity. The relative amount of HIF-
1α mRNA = absorbance value of HIF-1α’s ampliﬁcation
product/absorbance value of GADPH’s.
To detect the expression of HIF-1α protein in super-
natant, ELISA was used. The medium of HIF-1α gene
transfectedandnontransfectedMSCswereloadedon6pores
separately and ischemic and anoxic preconditioning for 2
hours while reaching 80∼90% conﬂuence, then abandoned
the culture solution. Washed twice with the precooled PBS
and fully schizolyed by Schizolysis balanced solution (Tris
5 0 m M ,E D T A3 M m ,M g C l 2 1mM, 1% Triton X-100),
cells were collected and centrifugated at 16000rpm 4◦Cf o r
10 minutes, then the supernatant was collected and sub-
packaged. Following the protocols listed in the instructions
manual strictly, the rat ELISA kit was used. The standard
immunoreagent was diluted to 1mL with sample dilution
and its density were 10000pg/mL, 5000pg/mL, 2500pg/mL,
1250pg/mL, 625pg/mL, 312pg/mL, AND 156pg/mL, as
series multiproportion dilution. The stock solution was
considered as the highest normal concentration directly,
the sample diluent was considered as normal concentration
0pg/mL, it was dispensed in 15 minutes before using it.
Diluted the supernatant liquid according to the ratio sample
diluent:supernatant = 1 : 20, then detected it.
To detect the expression of HIF-1α p r o t e i ni nM S C s ,
Western Blot was used. Concentration of the protein was
detected by using Bradford. In brief, 2 × sample buﬀer was
addedtoequivalentsampleaccordingtoconcentrationofthe
protein, denaturated at 100
◦Cf o r5m i n u t e s ,t h e np e r f o rm e d
SDS-PAGE electrophoresis (25μg/pore) at constant voltage
120v. After that, protein was transferred to NC membranes
(Nitrocellulose membranes) at 120v for about 2 hours.
Subsequently, the membrane was blocked by a blocking
buﬀer (5% dried skim milk, 25mm Tris-buﬀer saline TBS)
for 2 hours. Followed by incubation with rabbit antirat
HIF-1α antibody (diluted 1 : 1000, GAPDH 1 : 10000)
2322
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Figure 1: HIF-1α expression by RT-PCR is shown by the red arrow.
Lanes 1 and 3 are negative control and lane 2 denaturated at 58
◦C,
lane 4 at 62
◦C. Lane M is λDNA/Hind III.
at room temperature for 1 hour. Next the membrane was
washed three times with TBST for 10∼15 minutes each
time, incubated with horseradish peroxidase-conjugated
secondary antibody (diluted 1 : 1000) and antiGAPDH
mono-antibody at room temperature for 1 hour, and washed
again.FinallyECLreagentwasadded.5minuteslatertheﬁlm
wasexposed,developedandﬁxed.Theanalysisofabsorbance
was done by using Genesnap/Genetools software. Relative
expression of protein in each group wasexpressed by contral:
GAPDH.
3. Results
3.1. Ampliﬁcation of RT-PCR. The HIF-1α production
ampliﬁed by primer 1 and primer 2 were, as predicated,
located near 2480bp (Figure 1). The renaturation temper-
ature of lanes 2 and 4 were 58
◦Ca n d6 2
◦C, respectively,
and the positive expression can be observed at lane 4 more
pronounced.
3.2. Identiﬁcation of HIF-1α Plasmid. White clone 1∼3w a s
double digested with EcoR I and Sal I (Figure 2(a)). T vector
band (about 3000bp) and HIF-1α band (about 2480bp)
were showed in clones 1 and 2, which were positive clones
andcanbeveriﬁedbysequencinganalysis.HIF-1α-pcDNA3.1
and pcDNA3.1 empty vector were digested with Hind III and
BamH I, the objective bands were cut under ultraviolet lamp
and ligated overnight in vitro. Then the ligation product was
transformedintoJM109escherichiacoli,followedbymanual
plasmid extraction and identiﬁcation by double digestion
(Figure 2(b)).
3.3. Sequencing Analysis. The base sequence of inserted gene
intopcDNA3.1 wascompletelycoincidencewiththesequence
of HIF-1α by GenBank.4 Journal of Biomedicine and Biotechnology
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Figure 2: (a) The results of HIF-1α-T vector double digestion with EcoR I and Sal I. 1–3: Clones 1–3; m:λDNA/Hind III; M:DNA marker;
Clones 1 and 2 were positive clone. Red arrow showed the HIF-1α band, and yellow arrow showed the T vector band. (b) The results of
HIF-1α-pcDNA3.1 vector double digestion with Hind III and BamH I. 2-1: HIF-1α-pCDNA3.1 positive clone; 2-2: pcDNA3.1 empty vector;
M: DL 2000. Red arrow showed the HIF-1α band, and black arrow showed the pCDNA3.1 vector band.
3.4. Isolation, Culture, and Identiﬁcation of MCSs
3.4.1. The Growth and Morphologic Characters of MSCs. A
layer of monocyte between the separating medium and the
rinse solution was obtained by adding 1.073g/mL Percoll
solution in MSCs. The MSCs were adhered to the culture
bottles 24 hours after the plantation with fusiform shapes,
and 72 hours later these cells’ attachments became much
more pronounced and most of them begin to expand to
form pseudopodia. 3–5 days after the plantation, those
suspension cells that underwent necrosis were removed. The
remained MSCs proliferated in colonies and after cultured
for 6-7 days, the nucelus enlarged which contains 1–3
n u c l e o l u s .T h ee x t r a c e l l u l a rc o n n e c t sw e r ef o r m e dg r a d u a l l y
as the proliferating of cell colonies which irradiate from
single points or arranged in a vortex. 10–12 days later, the
cell conﬂuens reached to 80–90% and the primary culture
ended (Figure 3). After passage, the new daughter MSCs
begin to adhere within few hours and completely adhere to
bottlers within 24 hours and then entered to the logarithm
proliferative phase during which the number of MSCs
doubled within 2-3 days and conﬂuened within 5–7 days
in spindle, triangle and polygon shapes with pronounced
nucleus. The resulted MSCs after 3–5 times passage kept a
high proliferative speed and the speed began to slow down
after 7 times passage and faded gradually.
3.4.2. Identiﬁcation of the Surface Markers of MSCs. The
growth curve of 3rd and 5th generation MSCs had the shape
of S; the OD value was not changed markedly at the ﬁrst 1-2
days (incubation phase), followed by the logarithmic growth
phase during which the cells proliferated quickly occurred at
2-3 days and then by platform phase during which cellular
contact inhibition occurred at 6–8 days. The mean passage
period was 6–8 days (Figure 4).
Immunophenotypic analysis by FACS of cells after four-
cell passages showed that cells expressed high level of CD44
(94.7%) and SH3 (97.3%). Cells did not express CD34
(3.84%) or CD45 (2.73%) (Figure 5).
3.4.3. Diﬀerentiation of MSCs. A f t e r1 4d a y s ,am a s so f
calciumsalinityaccumulated(Figure 6),whichwasredwhen
stained by alizarin S (Figure 7).
The shape of cells changed after day 14 of induced
culturing and few fat drops appeared (Figure 8). After 21
days, more than 80% of cells diﬀerentiated into lipid-laden
cells which were stained by Sudan IV (Figure 9).
3.5. Transfection of HIF-1α into MSCs
3.5.1. Observation of Fluorescence and Transient Transfection
Eﬃciency. Weak and little ﬂuorescence was found at 12
hours after transfection under ﬂuorescence microscope; at
24 hours, dark green ﬂuorescence appearred; during 48∼
72 hours, positive cells increased and ﬂuorescent intensity
strengthened; ﬂuorescent intensity reached the peak level at
72 hours and lasted about 1 week, which became bright
greenﬂuorescence;thentheintensitydecreased,butlocalized
and diﬀuse ﬂuorescence can be found continued to 4 weeks.
With the best transfection program, the transfected cells can
maintain favorable growth cycle, and the cells in each phase
displayed the proliferation or division state can be observed
(Figure 10).Journal of Biomedicine and Biotechnology 5
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(d) (e) (f)
Figure 3: Morphology of MSCs in primary culture (100×). The primary cultured cells ﬂoated in medium and had a uniformed globular
shape (a). 3-4 days later, the cells adhered to the bottle began division growth (b) and the proliferated cell had a long fusiform shape
containing 1–3 nucleolus 5-6 days later (c). The cell colony can be seen 7–9 days later (d) and contact inhibition can be observed 10–12 days
later (e). The 3rd generation MSCs was well-distributed as ﬁbroblast.
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Figure 4: The growth curve of MSCs.
The transfer eﬃciency is aﬀected greatly by many factors.
In this study, fews tranfection procedures were attempted
to obtain the optimal transfection rate. When the mix
proportion of DNA and liposome was 1 : 3(μg:μL), cell
density was (1 × 105/mL/pore), incubation time was 5 hours
and cell conﬂuence was 78–80%, and the transfer eﬃciency
rate is 16.3% (Figure 11).
3.5.2. RT-PCR. The results from gene transfected or non-
transfected MSCs were shown in Figure 12. The length of
GAPDH production was 459bp and the length of HIF-1α
was 2.5kb. Under hypoxia conditions, both HIF-1α gene
transfected (lane 1) and nontransfected (lane 2) MSCs can
express HIF-1α, but the expression in the gene transfected
group was higher.
3.5.3. ELISA. ELISA found that both gene transfected and
nontransfected MSCs produce HIF-1α protein, but the con-
centration was higher in the transfected group (Figure 13).
3.5.4. Western Blot. The protein lanes from gene transfected
ornontransfectedMSCswereshowninFigure 14.Thelength
of GAPDH production was 37KD and the length of HIF-1α
was 120KD. Under hypoxia conditions, both HIF-1α gene
transfected (lane 1) and nontransfected (lane 2) MSCs can
express HIF-1α, but the expression in the gene transfected
group was higher.
4. Discussion
Hypoxia inducible factor-1α, a transcriptional neucleopro-
tein synthetized by cells subjected in hypoxia circumstance,
is the ﬁrst discovered heterodimeric DNA-binding complex
which can bind with the hypoxia response element in the
reinforce factor of erythrogenin gene. And after binding with
the target gene, through transcription and posttranscription
regulation, HIF-1α improves the tissues tolerance of hypoxia
and ischemia and therefore maintains the oxygen homeosta-
sis.
Researches related HIF-1 has been started, Kido et al.
[4] have shown that the over-expression of HIF-1α can6 Journal of Biomedicine and Biotechnology
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Figure 5: Cell marker expression CD44 (97.7%), SH3 (97.3%), CD34 (3.84%), and CD45 (2.73%).
signiﬁcantly contract the heart-infarcted area 4 weeks after
the onset of ischemia, increase the capillary density near
the infarcted zone and improve the expression of VEGF and
iNOS in transgenic mice which contained HIF-1α regulated
by promoter of myosin α2 H-chain, indicating the regulation
ofactivityofHIF-1αmaybeaneﬀectiveapproachtotreatthe
ischemic heart disease. Lee and his coworkers [5]r e p o r t e d
that the myocardium specimen from acute ischemic heart
disease patients expressed HIF-1α gene and the expression
of HIF-1α proceeded to that of VEGF, while the normal
myocardium specimen did not express HIF-1α or VEGF. Lee
and his team speculated that the over expression of HIF-1α
is the earliest adaptive reaction at molecular level in case of
myocardial ischemia.
Using exogenous angiogenesis factors to facilitate the re-
vascularization of ischemic myocardium is a novel strategy
for the advanced severe diﬀuse coronary heart disease.
Recently, exogenous genes VEGF and FGF have drawn the
majority attention, though they are just part of lots of
genes promoted in the process of angiogenesis. And the
eﬀects of VEGF therapy is still under controversy, serial
studies have shown the positive eﬀect while some researchers
focused on the concern of side eﬀect of VEGF therapy [6–
8] including the leakage of newly formed vessels, endothelial
dysfunction and inﬁltration of inﬂammatory cells. Arbeit et
al. [9] ampliﬁed HIF-1 by genetic engineering modiﬁed mice
skin cells, found the gene modiﬁed mice had yielded 66%
more capillaries as compared to the control mice and, asJournal of Biomedicine and Biotechnology 7
Figure 6: Calcium salinity accumulated after induced culturing
(100×).
Figure 7:CalciumsaltswereredwhenstainedbyAlizarinS(100×).
Figure 8: Fat drops present after day 14.
expected, higher expression of VEGF, and more importantly,
those extra new vessels had normal function without any
VEGFassociatedleakage.Arbeitsuggestedthatregulatingthe
HIF-1 is regulating all the angiogenesis related genes.
Eukaryotic expression vector pcDNA3.1 (National
Genetic Laboratory, China), designed for the high
performance of cDNA in mammalian cell [10], was
used in our study to construct the stably eﬀective gene
expression vector system. The lengthen of pcDNA3.1 is
5427bp. pcDNA3.1 has the character of copy easy and
stable, and moreover, can be integrated with enhanced
green ﬂuorescent protein (eGFP) report gene, which can
autocatalysis to form luminous structure and emitting green
ﬂuorescent under blue laser. eGFP can be expressed in many
kindsofspeciessuchasbacterium,myxomycete,yeast,plants
and mammal animals without any genus dependence. The
ﬂuorescent intensity of eGFP is high enough to be observed
Figure9:FatdropswereredwhenstainedwithSudanIVandnuclei
were blue when stained.
Figure 10: MSCs in multiplicative division emit ﬂuorescence.
under common ﬂuorescent microscope and require no
reaction substrate or help factors.
The methods of vector construction include cohesive
end ligation, blunt end ligation and T-A ligation. Blunt
end ligation is direct and simple. Although the ligation
eﬃciency of this method is low, it can be elevated by using
some strategies, such as raising the density and ratio of
inserted fragment, 5  phosphorylating the blunt end linear
vector, blunting and phosphorylating the PCR products,
and adding some ligation accelerators in the system. Some
thermostable polymerases, such as Tag DNA polymerase,
can perform cohesive end ligation of the PCR products with
the T terminal of vector during the process of ampliﬁcation
and extension. This enzyme improves the eﬃciency of PCR
ligationwithoutfurthertreatment.Inthisresearch,wefound
that PCR products were lost greatly during puriﬁcation pre-
and postenzyme digestion. So we failed at the beginning,
until we increased PCR products leading to the success of
ligation. Because the length of the fragment of HIF-α cDNA
is greater than 2Kb, we used high ﬁdelity HotStar enzyme
of QIAGEN company in this research, which signiﬁcantly
increased the positive fragment and decreased the nonspe-
ciﬁc bands in ampliﬁcation. The result of ampliﬁcation was
conﬁdent and satisfactory for the fragment without any base
variation conﬁrmed by sequencing. In this research, HIF-
α gene was cloned from rat myocardial cells by RT-PCR.
Then using T vector clone method to select positive cone.
The cultured bacteria further received plasmia extraction,
electrophoresis, and double enzyme digestion. So we can8 Journal of Biomedicine and Biotechnology
(a) (b) (c)
Figure 11: Transfecton eﬃcency = (The number of cells expressing green ﬂorescence/The number of cells expressing blue ﬂorescence) ×
100%, and the average value obtained from 3∼4 visual ﬁeld. (a) The cells type and Hoechst33342 stained nucleus that showed light blue
under optical microscope. (b) Hoechst33342 can directly permeate the normal membrane and dye the DNA of viable cells, which showed
the nucleus expressed blue ﬂuorescence. (c) The cells transfected with HIF-1α-pcDNA3.1/eGFP, showed green ﬂuorescence with whole cell
type.
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Figure 12: Expression of by RT-PCR. Lane 1 was for HIF-1α-
pcDNA3.1 transfected MSCs and lane 2 for nontransfected, lane M
for DL2000 as reference.
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Figure 13: Detection of HIF-1α protein by ELISA. The transfected
group (top) had a higher concentration as compared with the
nontransfected group.
initially aﬃrm weather exogenous gene (the fragment is
about 2.5Kb) is inserted. After conﬁrmed by sequencing,
the target fragment was cloned into eukaryotic expression
vector pcDNA3.1. It was veriﬁed in our research work that
this program was convenient, eﬃcient, quick, and reliable,
which did some basic work for the further research.
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Figure 14: Expression of by Western blot. Lane 1 was for HIF-1α-
pcDNA3.1 transfected MSCs and lane 2 for nontransfected, lane M
(biotinylated protein ladder).
MSCs, early cells of the mesoderm, are cell populations
excluding hematopoietic stem cell, have the plasticity to
diﬀerentiate into multiple tissues. The steady culture system
for MSCs has been set up previously [11], and in this culture
system, 3 × 104 primary cells can be obtained from each
Wistar mouse, and the cell number can be reached to 1
× 108 after three passages at the rate of 1 : 3. In this
study, inspecting the surface antigens with ﬂow cytometry
combined with diﬀerentiation tests were used to identify
cultured MSCs, and we examined four markers, and the cells
shown in the result were SH3+, CD34–, CD45–, and CD44+,
which are consistent with the quality of MSCs.
How to eﬀectively transfer the target gene, HIF-1α-
pcDNA3.1/eGFP,intothevectorcell,MSCs,wasthekeypoint
of this study. Selections of gene transport vehicle, viral vector
or liposome, are associated to the safety of gene therapy
directly. Two severe incidents occurred in 1999 and 2002
has raised great concern about the application perspective of
viral vector [12, 13]. Liposomes, composed by phospholipid
bilayer, are kind of lipoid containing a hydrophilia inner
core. When used as gene transfer vector, liposomes have lowJournal of Biomedicine and Biotechnology 9
transfect eﬃciency but a high safety. The main advantages of
liposomes as gene transfer vector are the following: protect
the DNA plasmid from degradation by nucleinase, can be
biodegradated,easytomanipulate,withoutimmunogenicity,
adapted to both separating cells and unseparated cells, and
no limitation for the size of exogenous gene. Therefore,
positive ion Lipofectmin2000 was chosen as the transfer
vector in this study. The transfer eﬃciency of liposomes
is aﬀected by the following parameters [14, 15]: (1) the
mix proportion of liposome and DNA; (2) incubation time
and (3) the concentration of blood serum in medium.
In our study, the expression of exogenous gene was far
lower when the MSCs reaching fully conﬂuence and the
contact inhibition occurred, as compared to the growth
conﬂuencerateof70–80%,whichindicatethecellsinmitotic
cycle facilitate the expression of exogenous gene transfected
by liposomes. The process of entering nuclear is the rate
determining step of the transfection mediated by positive
ion liposomes, which may be carried by two diﬀerent ways
[16]: (1) passively enter the nuclear during mitotic phase
and (2) actively enter the nuclear through the nuclear pore.
And therefore, the expression eﬃciency of exogenous gene
is restricted by the mitotic phase which resulting the lower
rate of liposomes [17]. For obtaining the best transfection
eﬃciency, we used the best cell density (1 × 105/1mL/hole),
convergence degree (70∼80% conﬂuence), and transfection
reaction time (5 hours) recommended by Lipofectmine2000
kit. Referred documents and tested from our preliminary
experiment, the best ratio of DNA to liposome volume was
DNA: LP2000 (μg:μL) = 1:3 .I tm e a n s3 μL LP2000
mediated 1μgH I F - 1 α gene leading to the best transfection
eﬃciency [18, 19]. In addition, the incubation time is also
important. We tried 12 hours, 8 hours, 6 hours, 4 hours,
and 2 hours as incubation time, respectively, the result
showed that longer incubation time was associated with
higher transfection eﬃciency and higher cellular death rate,
while the shorter incubation time could improve the cell
survival rate, but the tranfection of exogenous gene was
compromised (data not showed in this paper). Finally the
5-hour incubation time was used because both the cell
death rate and the transfection eﬃciency were acceptable.
Furthermore, the serum-free DMEM cultivation should be
used in the process of transfection. Because the serum
contains protein with negative charge and lipid with positive
charge, which can reduce the ability of liposome contacting
with DNA to form compound.
With hypoxia induction, 48 hours after HIF-1α-
pcDNA3.1/eGFP transfecting MSCs mediated by LP2000,
the result of RT-PCR showed transgenic MSCs contained
mRNA of HIF-1α protein, which can be veriﬁed by HIF-
1αexpressingintranscriptionallevel.Immunocytochemistry
and ELISA examination showed: transfected cells expressed
target product—HIF-1α protein. Compared with control
group, the supernatant of experiment group contained
higher HIF-1α protein. Therefore, we inferred that if trans-
planting the target cells which received hypoxia induction
and transfected within 3 days into ischemic myocardium,
the cells can express and secrete HIF-1α in ischemic cir-
cumstance, and in turn, the expressed HIF-1α can further
ameliorate the survival condition of transplanted cells.
Through the quantitative experiment, M¨ uller-Ehmsen et al.
[20] conﬁrmed that the number of transplanted exogenous
cells in myocardium decreased quickly in short time, which
maybe related to the apoptosis induced by ischemia and
hypoxia. Y. L. Tang et al. [21] found that the tolerance and
instability of transplanted cells ameliorated greatly when
transplanted MSCs transfected with hypoxia regulated heme
oxygenase-1 (HO-1) gene into ischemic myocardium. HO-
1 gene is the downstream gene of HIF-1α, so transfecting
HIF-1α into MSCs will has more advantage. Now, there is
no report of MSCs transfected with HIF-α mediated by lipo-
some transplanting into myocardium at home and abroad.
Wewillmakefurtherresearchinournextexperimentinvivo.
Using MSCs as mediated cells in transgenic process can
greatly improve the eﬃciency of HIF-1α gene treatment.
Its advantages include (1) the target cells transplanting
after gene transfection in vitro avoids the liposome directly
contacting with body, decreasing the potential toxicity;
(2) the transfection eﬃciency and result controllability are
satisfactory.Itisinducedbyhypoxiaandwillnotoverexpress;
(3) cell treatment and gene therapy have synergistic eﬀects.
MSCs can diﬀerentiate into endothelial cell and cardiac
myocyte in microenvironment in vivo and repair damaged
myocardium.
Using lipofectamine mediating HIF-1α-pcDNA3.1/eGFP
transfected target cells in vitro, the target gene gets good
expression and secretion. To ischemic hart disease with the
structure cells lose, this method has the function of killing
two birds with one stone. Now, people are making researches
in some new liposomes, such as long-circulating liposome,
thermosensitive liposome, and ph-sensitive liposome [22]. It
can be believed that the transfection eﬃciency of liposome
will be improved in the future. In the process of ischemic
heart disease treatment, the strategy of using donorcells with
target gene to rebuild the structure of ventricle wall will
have favorable prospect of development in the forthcoming
biotherapy.
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